Cutaneous sporotrichosis treated with photodynamic therapy: An in vitro and in vivo study

Yolanda Gilaberte, Carmen Aspiroz, M. Carmen Alejandre, Elena Andres-Ciriano, Blanca Fortuño, Luis Charlez, Maria Jose Revillo, Michael R. Hamblin, Antonio Rezusta

Research output: Contribution to journalArticlepeer-review

41 Citations (Scopus)

Abstract

Background: Sporotrichosis is a fungal infection caused by Sporothrix schenckii complex, usually restricted to the skin, subcutaneous cellular tissue, and adjacent lymphatic vessels. Antimicrobial photodynamic therapy (aPDT) could be a good alternative to manage localized, superficial infections. Case report: A 65-year-old African woman was diagnosed with a fixed cutaneous sporotrichosis on her left arm, treated with itraconazol and oral terbinafine with partial improvement. Topical 16% methyl aminolevulinate (MAL, Metvix®)- PDT was used without success. Methods: An in vitro photoinactivation test with the isolated microorganism revealed phenothiazinium salts to be more effective than MAL. Conclusions: PDT with intralesional 1% methylene blue (MB) in combination with intermittent low doses of itraconazole obtained complete microbiological and clinical response.

Original languageEnglish
Pages (from-to)54-57
Number of pages4
JournalPhotomedicine and Laser Surgery
Volume32
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

ASJC Scopus subject areas

  • Biomedical Engineering
  • Radiology, Nuclear Medicine and Imaging

Fingerprint

Dive into the research topics of 'Cutaneous sporotrichosis treated with photodynamic therapy: An in vitro and in vivo study'. Together they form a unique fingerprint.

Cite this